Testicular Modulation of Luteinizing Hormone Response to Gonadotropin- Releasing Hormone (GnRH)-Agonist Treatment
- 1 March 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 36 (2) , 309-313
- https://doi.org/10.1095/biolreprod36.2.309
Abstract
We and others have observed that the response of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to chronic gonadotropin-releasing hormone-agonist (GnRH-A) treatment is substantially different in normal compared to hypogonadal males. These data suggested that products of the testes determine the gonadotropin response to GnRH-A. The present studies were designed to determine whether this effect is mediated by products of the interstitial (steroids) or the tubular compartment. To create experimental states with selective impairment of interstitial, tubular, or both compartments, 100 male sexually mature Wistar rats were divided into five groups: I, intact; II, castrated; III, castrated with 20-mm testosterone (T) implants: IV, bilaterally cryptorchid; and V, ketoconazole-treated animals. Cryptorchid animals have been shown to have impairment of tubular function while ketoconazole inhibits T biosynthesis. Each of the 5 groups was divided into 2 subgroups to receive daily injections of either saline or 1 .mu.g of a potent GnRH agonist, D-leu6 des-Gly10 GnRH N-ethylamide, for 4 wk. Unlike the intact animals, which showed an elevation of basal serum LH concentration after 4 wk of GnRH-A treatment, the castrated animals showed significant suppression below baseline. Animals with preferential impairment of tubular function (cryptorchid and castrated + T) also showed significant suppression of LH after GnRH-A treatment. However, the ketoconazole-treated animals (with inhibition of T biosynthesis and intact tubular function), behaved similarly to intact animals and demonstrated an elevation of LH after GnRH-A treatment. We conclude that 1) testes regulate gonadotropin response to chronic administration of GnRH-A and 2) testicular modulation of gonadotropin response to GnRH-A may be mediated, at least in part, by products of the tubular compartment.This publication has 12 references indexed in Scilit:
- In VitroInhibition of Testosterone Biosynthesis by KetoconazoleEndocrinology, 1985
- Suppression of Pituitary and Testicular Function in Normal Men by Constant Gonadotropin-Releasing Hormone Agonist InfusionJournal of Clinical Endocrinology & Metabolism, 1984
- Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer.Journal of Clinical Investigation, 1983
- Ketoconazole blocks testosterone synthesisArchives of internal medicine (1960), 1982
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.Journal of Clinical Endocrinology & Metabolism, 1982
- Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal MenNew England Journal of Medicine, 1981
- THERAPEUTIC USE OF PITUITARY OESENSITIZATION WITH A LONG-ACTING LHRM AGONIST: A POTENTIAL NEW TREATMENT FOR IDIOPATHIC PRECOCIOUS PUBERTY*Journal of Clinical Endocrinology & Metabolism, 1981
- Down-Regulation of Pituitary Gonadotropin Secretion in Postmenopausal Females by Continuous Gonadotropin-Releasing Hormone Administration*Journal of Clinical Endocrinology & Metabolism, 1981
- Testosterone and the Control of Gonadotropin Secretion in the Male Rhesus Monkey (Macaca mulatto)*Endocrinology, 1978
- Secretion of an FSH-Inhibiting Factor by Cultured Sertoli CellsEndocrinology, 1976